MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.

CANF Can-Fite BioPharma Ltd Forecast, Technical & Fundamental Analysis

a developer of biopharmaceuticals for treatment of autoimmune diseases and cancers

Industry Biotechnology
CANF
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For CANF
(Try 14 days for Free)
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CANF
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For CANF
(Try 14 days for Free)
Ad is loading...
A.I. Advisor
published Earnings

CANF is expected to report earnings to rise 767.00% to -8 cents per share on March 23

Can-Fite BioPharma Ltd CANF Stock Earnings Reports
Q4'22
Est.
$-0.09
Q3'22
Beat
by $0.08
Q2'22
Beat
by $0.04
Q1'22
Beat
by $0.14
The last earnings report on November 25 showed earnings per share of 0 cents, beating the estimate of -9 cents. With 94.52K shares outstanding, the current market capitalization sits at 9.17M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals for treatment of autoimmune diseases and cancers

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
26 Ben Gurion Street
Phone
+972 39241114
Employees
5
Web
http://www.canfite.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

CANF and Stocks

Correlation & Price change

A.I.dvisor tells us that CANF and LGVN have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CANF and LGVN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANF
1D Price
Change %
CANF100%
-5.96%
LGVN - CANF
30%
Poorly correlated
-2.20%
RNA - CANF
29%
Poorly correlated
-1.95%
RLMD - CANF
28%
Poorly correlated
-6.97%
ZLAB - CANF
25%
Poorly correlated
+3.02%
ARWR - CANF
25%
Poorly correlated
-0.45%
More